rs17279437

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP3BP4_StrongBP6_Very_StrongBA1

The NM_020208.4(SLC6A20):​c.596C>T​(p.Thr199Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0894 in 1,612,876 control chromosomes in the GnomAD database, including 7,209 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.066 ( 424 hom., cov: 32)
Exomes 𝑓: 0.092 ( 6785 hom. )

Consequence

SLC6A20
NM_020208.4 missense

Scores

10
2
5

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5O:1

Conservation

PhyloP100: 8.14

Publications

72 publications found
Variant links:
Genes affected
SLC6A20 (HGNC:30927): (solute carrier family 6 member 20) Transport of small hydrophilic substances across cell membranes is mediated by substrate-specific transporter proteins which have been classified into several families of related genes. The protein encoded by this gene belongs to the sodium:neurotransmitter symporter (SNF) family and functions as a proline transporter expressed in kidney and small intestine. Mutations in this gene are associated with Hyperglycinuria and Iminoglycinuria. [provided by RefSeq, Jul 2020]
SLC6A20 Gene-Disease associations (from GenCC):
  • hyperglycinuria
    Inheritance: Unknown, AR, AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 8: BayesDel_noAF, Cadd, Eigen, MutationAssessor, phyloP100way_vertebrate, PROVEAN, REVEL, REVEL [when AlphaMissense, BayesDel_addAF, max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.006226331).
BP6
Variant 3-45772602-G-A is Benign according to our data. Variant chr3-45772602-G-A is described in ClinVar as Benign. ClinVar VariationId is 4845.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0956 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020208.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC6A20
NM_020208.4
MANE Select
c.596C>Tp.Thr199Met
missense
Exon 5 of 11NP_064593.1Q9NP91-1
SLC6A20
NM_001385683.1
c.596C>Tp.Thr199Met
missense
Exon 5 of 11NP_001372612.1A0A8V8TQV4
SLC6A20
NM_001406066.1
c.596C>Tp.Thr199Met
missense
Exon 5 of 11NP_001392995.1B7ZLW4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC6A20
ENST00000358525.9
TSL:1 MANE Select
c.596C>Tp.Thr199Met
missense
Exon 5 of 11ENSP00000346298.4Q9NP91-1
SLC6A20
ENST00000353278.8
TSL:1
c.583-1144C>T
intron
N/AENSP00000296133.5Q9NP91-2
SLC6A20
ENST00000962429.1
c.460C>Tp.Arg154Trp
missense
Exon 5 of 11ENSP00000632488.1

Frequencies

GnomAD3 genomes
AF:
0.0659
AC:
10025
AN:
152124
Hom.:
424
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0189
Gnomad AMI
AF:
0.0614
Gnomad AMR
AF:
0.0497
Gnomad ASJ
AF:
0.115
Gnomad EAS
AF:
0.00654
Gnomad SAS
AF:
0.0394
Gnomad FIN
AF:
0.100
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0976
Gnomad OTH
AF:
0.0492
GnomAD2 exomes
AF:
0.0717
AC:
17750
AN:
247566
AF XY:
0.0726
show subpopulations
Gnomad AFR exome
AF:
0.0173
Gnomad AMR exome
AF:
0.0466
Gnomad ASJ exome
AF:
0.116
Gnomad EAS exome
AF:
0.00491
Gnomad FIN exome
AF:
0.104
Gnomad NFE exome
AF:
0.0967
Gnomad OTH exome
AF:
0.0679
GnomAD4 exome
AF:
0.0918
AC:
134120
AN:
1460634
Hom.:
6785
Cov.:
31
AF XY:
0.0903
AC XY:
65619
AN XY:
726600
show subpopulations
African (AFR)
AF:
0.0132
AC:
441
AN:
33466
American (AMR)
AF:
0.0471
AC:
2102
AN:
44626
Ashkenazi Jewish (ASJ)
AF:
0.115
AC:
3003
AN:
26112
East Asian (EAS)
AF:
0.00912
AC:
362
AN:
39674
South Asian (SAS)
AF:
0.0404
AC:
3482
AN:
86090
European-Finnish (FIN)
AF:
0.0997
AC:
5306
AN:
53202
Middle Eastern (MID)
AF:
0.0244
AC:
141
AN:
5768
European-Non Finnish (NFE)
AF:
0.103
AC:
114459
AN:
1111334
Other (OTH)
AF:
0.0799
AC:
4824
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
6136
12272
18409
24545
30681
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4140
8280
12420
16560
20700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0659
AC:
10030
AN:
152242
Hom.:
424
Cov.:
32
AF XY:
0.0648
AC XY:
4826
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.0188
AC:
781
AN:
41544
American (AMR)
AF:
0.0499
AC:
764
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.115
AC:
398
AN:
3466
East Asian (EAS)
AF:
0.00656
AC:
34
AN:
5186
South Asian (SAS)
AF:
0.0396
AC:
191
AN:
4820
European-Finnish (FIN)
AF:
0.100
AC:
1064
AN:
10600
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0976
AC:
6635
AN:
68002
Other (OTH)
AF:
0.0487
AC:
103
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
483
966
1449
1932
2415
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
122
244
366
488
610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0847
Hom.:
2555
Bravo
AF:
0.0596
TwinsUK
AF:
0.0909
AC:
337
ALSPAC
AF:
0.102
AC:
392
ESP6500AA
AF:
0.0204
AC:
85
ESP6500EA
AF:
0.0994
AC:
837
ExAC
AF:
0.0702
AC:
8496
Asia WGS
AF:
0.0270
AC:
97
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Hyperglycinuria (3)
-
-
2
not provided (2)
-
-
1
SLC6A20-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.087
T
BayesDel_noAF
Pathogenic
0.18
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Benign
0.28
T
Eigen
Pathogenic
0.84
Eigen_PC
Pathogenic
0.74
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.99
D
MetaRNN
Benign
0.0062
T
MetaSVM
Benign
-0.43
T
MutationAssessor
Pathogenic
4.2
H
PhyloP100
8.1
PrimateAI
Uncertain
0.52
T
PROVEAN
Pathogenic
-5.5
D
REVEL
Pathogenic
0.72
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.58
MPC
0.88
ClinPred
0.079
T
GERP RS
5.3
Varity_R
0.84
gMVP
0.83
Mutation Taster
=87/13
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17279437; hg19: chr3-45814094; COSMIC: COSV62072026; COSMIC: COSV62072026; API